NYC Early-Stage Venture in 2026: Who's Writing Seed Checks Today

New York’s early-stage ecosystem in 2026 centers on applied B2B SaaS, fintech, digital health, and vertical AI. Below is a pragmatic 2026 map of active seed investors and current themes.

Most active NYC seed funds in 2026

• Primary Ventures — $625M Fund V, seed-focused; leads 10–15 NYC rounds/year.
• Lerer Hippeau — broad NYC seed, consumer and SaaS.
• Lux Capital — science/deep-tech leaning.
• Union Square Ventures — later-stage-anchored, but backs seed.
• Contour Venture Partners — B2B SaaS and fintech, classic NYC seed.
• FirstMark — long-running NYC generalist.
• BoxGroup — multi-sector, check-size flexible.
• Bowery Capital — B2B SaaS specialist.
• Bloomberg Beta — machine intelligence focused.
• Greycroft — NY + LA, consumer & enterprise.

What’s funding well in NYC right now

1. Agentic finance/billing: Zenskar, Orb, Ramp-adjacent tooling.
2. Applied healthcare AI: Avo, Patlytics, Faireez-like verticals.
3. Vertical SaaS with payments: Cents, Dave-style verticals.
4. Security: Promptlayer, Dataminr-like data/safety tooling.
5. Consumer subscription + commerce: select, fewer deals.

Practical takeaway (founder + investor)

1. Founders: NYC investors reward repeatable revenue and customer depth more than narrative; come with usage data.
2. Investors: NYC’s 2026 upside is in applied verticals, not frontier AI; focus due diligence on retention and margin.

Sources

1. AlleyWatch daily funding reports (2026): https://alleywatch.com/2026/04/the-alleywatch-startup-daily-funding-report-4-17-2026/
2. Crunchbase Q1 2026: https://news.crunchbase.com/venture/record-breaking-funding-ai-global-q1-2026/